Author: AHFS

AHFS Clinical Drug Information Now Available

AHFS-CDI-200x242-revisedJust launched, AHFS Clinical Drug Information (AHFS CDI) is your comprehensive interactive treatment and drug therapy solution. It allows health professionals to quickly access the nation’s leading compendium of unbiased and authoritative drug information as well as other drug databases. Access real-time drug and safety alerts, including current drug shortages information. Available on a Google cloud-based platform for any mobile device, as well as an app for iOS devices, with Android coming soon.

 

View the new video to learn more about AHFS CDI.

 

Visit AHFS at MLA: Mosaic 16 in Toronto!

If you’re attending MLA: Mosaic 16, May 13th – 18th in Toronto, visit the ASHP booth, #726, and get an exclusive preview of AHFS Clinical Drug Information, the next big thing for easy access to real-time drug information and updates.

Sign up for more information about AHFS Clinical Drug Information and other ASHP products for institutions, and register for a chance to win a Fitbit Charge HR!

fitbit

The New AHFS Clinical Drug Information – Coming Soon

AHFS-CDI-200x242

Help Faster. Heal Smarter.
AHFS. Real time drug information to advance care.

For 58 years, you’ve counted on AHFS to make the most trusted drug and safety recommendations. Now, make those recommendations…FAST.

Coming in 2016, the new AHFS® Clinical Drug Information™ is your comprehensive, interactive treatment and drug therapy solution to optimize your time and advance care.

  • Real-time drug and safety updates
  • Quick clinical window—fast access to the most comprehensive, authoritative evidence-based drug information
  • Direct links to more than 60,000 supporting evidence sources
  • In-depth, unbiased coverage of off-label uses
  • Seamlessly incorporated FDA safety data
  • 87,000 references, including published research, therapeutic guidelines, and prescribing information
  • Designated official US compendium

Individual pricing starts as low as $10 per month for members and $15 per month for non-members. Institutional trials are available. Contact us for pricing information.